used the AD model of rats to verify whether DMY can exert the regulatory roles in AD via up-regulation of AMPK/SIRT1 signaling pathway to inhibit inflammatory responses, hippocampal neuronal apoptosis and ameliorate cognitive function, thus providing novel targets for the clinical treatment of AD (P. 70). The gene discussed is SIRT1; the disease is Alzheimer disease.